SARS-CoV-2 Spike site-specific N-linked glycan analysis
Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: 
Max Crispin
PROVIDER: MSV000085202 | MassIVE | Tue Mar 31 06:10:00 BST 2020
REPOSITORIES: MassIVE
Similar Datasets
Project description:Glycopeptide analysis of trypsin, chymotrypsin and alpha-lytic protease digests from SARS-CoV-2 Spike expressed in HEK 293F cells. Contains three biological replicates expressed separately
https://science.sciencemag.org/content/369/6501/330
2021-04-22 | MSV000087279 | MassIVE
Project description:This RNA-seq is a part of the paper describing the role of PIN5 in generating auxin sinks. https://www.biorxiv.org/content/10.1101/2024.01.24.576992v1
2024-03-31 | GSE260945 | GEO
Project description:The SARS-CoV-2 Delta variant is more contagious than WT and causes severe symptoms.To understand the elevated fusogenicity of Delta, we used LC-MS/MS to characterize the site specific N-linked glycan of spike protein in SARS-CoV-2 Delta variant virions.The glycan analysis revealed increased oligomannose-type glycosylation of native Delta spike over that of the Wuhan-Hu-1 spike.
2023-05-10 | PXD033342 | Pride
Project description:(i) RNA transcripts of Raji iBZLF1 cells (https://www.biorxiv.org/content/10.1101/573659v1) were compared between non-induced cells and cells induced with doxycycline (100 ng/ ml) for 6 h. Human (Hg19) as well as viral (EBV, Raji KF717093.1) transcripts were analyzed. Artificial ERCC Spike-ins (Thermo Scientific) were added to selected samples to control for global changes of RNA levels. (ii) For control purposes, the RNA transcripts in Raji cells equipped with a doxycycline-controlled truncated BZLF1 allele lacking its transactivation domain (Raji iBZLF1 AD-truncated) were prior to and after induction for 6 h. (iii) For another control, the RNA transcripts of parental, unmodified Raji cells were analyzed prior to and after doxycycline induction for 6 h. All experiments were performed as triplicates.
2019-01-01 | E-MTAB-7820 | biostudies-arrayexpress
Project description:Identification of the gene differentially expressed with and without a non-sense mutation in YAK1 gene. This analysis provided a better understanding of the mechanism underlying variants affecting differently mRNA and protein abundance of genes in TRANS. Data used in the preprint: https://www.biorxiv.org/content/10.1101/2020.07.02.185413v1
2020-08-11 | GSE155998 | GEO
Project description:This submission contains the data from https://www.biorxiv.org/content/10.1101/795047v2.full This dataset contains processed data of cell-free reduced representation bisulfite sequencing from 60 pediatric cancer samples, in order to classify them according to histopathological diagnosis. Files are provided in bismark coverage format. Samples were sequenced on a NextSeq 500.
2020-02-27 | E-MTAB-8770 | biostudies-arrayexpress
Project description:These files represent single cell RNA-Seq data generated on a 10x Chromium genomics platform from bioprinted iPSC-derived human kidney organoids differentiated according to our published protocol (Takasato et al., Nature Protocols 2016). The data contains >2000 cells that passed our QC. Data was used to confirm that bioprinted organoids contain a similar cellular composition as standard manually produced organoids - See https://www.biorxiv.org/content/10.1101/505396v1.
2020-09-01 | GSE138835 | GEO
Project description:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus utilizes an extensively glycosylated spike protein that protrudes from the viral envelope to bind to angiotensin-converting enzyme-related carboxypeptidase (ACE2) as its primary receptor to mediate host-cell entry. Currently, the predominant recombinant spike protein production hosts are Chinese hamster ovary (CHO) and human embryonic kidney (HEK) cells. In this study, recombinant full-size spike protein was produced transiently in CHO and HEK cell suspensions. To further evaluate the sialic acid linkages presenting on spike glycans, a two-step amidation process, employing dimethylamine and ammonium hydroxide reactions in a solid support system, was developed to differentially modify the sialic acid linkages on glycans and glycopeptides from spike protein. We determined global and site-specific N-linked glycosylation patterns in soluble SARS-CoV-2 spike using MALDI-TOF and LC-MS/MS with electron-transfer/higher-energy collision dissociation (EThcD) fragmentation. We identified the glycan compositions at 21 and 19 out of the 22 predicted N-glycosylation sites of the SARS-CoV-2 spike proteins produced in CHO and HEK, respectively. The N-glycan site at 1158 position (N1158) and the N-glycan sites at 122 ,282 and 1158 positions (N122, N282 and N1158) were found to be unoccupied on spike secreted from CHO and HEK cells, respectively. The structural mapping of glycans of recombinant human spike proteins revealed that CHO-Spike presented more complex and higher sialylation (α2,3-linked) content while HEK-Spike displayed more high-mannose and minor content of α2,3- and α2,6-linked sialic acids. The N74 site represents the most heavily N-glycosylated site on both spike proteins while some high-mannose abundant sites (N17, N234, N343, N616, N709, N717, N801 and N1134) on HEK-Spike may differentially shield the virus compared to CHO-spike and provide a different host immune system interaction strategy. Collectively, these data underscore the importance of characterizing site-specific glycosylation on recombinant human spike protein from HEK and CHO cells in order to better understand the impact of the production host on this complex and important protein used in diagnostics and vaccines.
2022-02-17 | PXD027536 | Pride
Project description:In this study, we analyzed recombinant SARS-CoV-2 Spike protein secreted from BTI-Tn-5B1-4 cells, by trypsin and chymotrypsin digestion followed by mass spectrometry analysis. We acquired MS/MS spectrums for glycopeptides of all predicted N-glycosylated sites and O-glycosylated sites.
2020-05-19 | PXD019282 |
Project description:Abstract
Glycopeptide Abundance Distribution Spectra (GADS) were recently introduced as a means of representing, storing and comparing glycan profiles of intact glycopeptides. Here, using that representation, an extensive analysis is made of multiple commercial sources of recombinant SARS-CoV-2 spike protein, each containing 22 N-linked glycan sites (sequons). Multiple proteases are used along with variable energy fragmentation, followed by ion trap confirmation. This enables a detailed examination of reproducibility of the method across multiple types of variability. These results show that GADS are consistent between replicates and laboratories for sufficiently abundant glycopeptides. Then derived GADS enable the examination and comparison of the glycan profiles between commercial sources of the spike protein. Throughout multiple distinct glycopeptide distributions, generated by multiple proteases, confirm these profiles. Comparisons of GADS derived from 11 sources of recombinant spike protein reveal that sources for which protein expression methods were the same produced near-identical glycan profiles, thereby demonstrating the ability of this method to measure GADS of sufficient reliability to distinguish different glycoform distributions between commercial vendors and potentially to reliably determine and compare differences in glycosylation for any glycoprotein under different conditions of production. GADS libraries for all 11 sources of recombinant spike protein have been made available for download (https://chemdata.nist.gov/dokuwiki/doku.php?id=peptidew:sars-cov-2_spike_protein_n_linked_glycoLC-MS/MS Analysis ).
LC-MS/MS Analysis
Spike protein digests were analyzed on an UltiMate 3000 (Thermo Fisher Scientific) in-line with an Orbitrap Fusion Lumos (Thermo Fisher Scientific) mass spectrometer. Reversed-phase separation was performed on an Acclaim PepMap RSLC 75 um x 75 cm column (Thermo Fisher Scientific) at a flow rate of 200 nL/min. The gradient consisted of (min: % Solvent B): 0:2, 320:32, 366:80, 383:98, 396:98, 409:2, 490:2, where solvent B is 0.1% (v/v) formic acid in acetonitrile.
Data-dependent acquisition was performed in positive ion mode with an ion transfer tube temperature of 275 C and a spray voltage of 1.80 kV. MS survey scans, or MS1 scans, were acquired with a scan range of m/z 380-2000, a maximum injection time of 50 ms, AGC target of 400 000 and RF Lens value of 40%. Precursor ions were detected in the orbitrap with a resolution of 120 000. Precursor ions selected for fragmentation included those with charge states 2-8 with a minimum intensity of 50 000. A dynamic exclusion of 15 seconds was used with a tolerance of +/- 10 ppm. Tandem mass spectra were acquired with a cycle time of 5 seconds in between MS1 scans, a maximum injection time of 60 ms, an AGC target of 50 000 and a fixed starting m/z of 120. Beam-type collision cell spectra (HCD) using stepped collision energies of NCE 15, 25 and 35% were acquired and detected in the orbitrap with a resolution of 30 000. An ion trap scan was triggered if m/z 204.087 (15 ppm tolerance) was among the top 20 product ions in the HCD scan. The ion trap scan was acquired with a collision energy of 30%, activation Q of 0.25 and activation time of 10 ms. Product ions were detected in the orbitrap with a resolution of 30 000.
Data Analysis
Glycopeptide assignments were made using Byonic and Byologic software (version 3.10 Protein Metrics, Inc.). For each protease, with the exception of alpha lytic proteases, up to three missed cleavages were allowed using cleavage rules listed in Table 2. Up to six missed cleavages were allowed for alpha lytic wild type and mutant proteases. Assignments were made using precursor and product ion tolerances of 5 and 20 ppm, respectively. Cysteines were required to contain a fixed carbamidomethyl while variable modifications included oxidation of methionine and N-terminal pyroglutamine. For glycopeptides, a library containing 445 N-glycans was used (Supplemental Table S1).
2023-04-21 | MSV000091776 | MassIVE